Reported results
- Net sales were $970 million for the third quarter of 2026.
- Net income attributable to Visteon was $5 million for the third quarter of 2026.
- Diluted earnings per share was $0.19 for the third quarter of 2026.
- Adjusted EBITDA, a non-GAAP measure, was $46 million for the third quarter of 2026.
- Adjusted free cash flow, a non-GAAP measure, was an outflow of $4 million for the nine months ended September 30, 2026.
- New business wins of $0.9 billion were secured during the third quarter of 2026.
Guidance
- Full-year 2026 sales guidance range of $3.80 – $3.85 billion
- Full-year 2026 adjusted EBITDA range of $370 – $410 million
- Full-year 2026 adjusted free cash flow range of $90 – $130 million
Notes
Amounts shown reflect the change in accounting principle related to the method for assessing the realizability of U.S. deferred tax assets described in the Company’s 2025 Form 10-K.
Price and volatility reaction
The stock moved -3.7% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved +0.0 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 84.83 | 2026-10-21 |
| Close after release | 81.7 | 2026-10-22 |
| Realised move | -3.7% | close to close |
| 30d ATM IV change | +0.0 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-22 (8-K, Item 2.02). Read the original filing on sec.gov.
